Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases

BACKGROUND: Krebs von den Lungen 6 (KL-6) is a sensitive marker for diagnosing, monitoring, and predicting the prognoses of interstitial lung diseases (ILDs). This study aimed to evaluate the performance of the Nanopia KL-6 assay (Sekisui Medical, Tokyo, Japan) and to test the relationship between K...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Lab Med
Päätekijät: Cho, Eun-Jung, Park, Kyoung-Jin, Ko, Dae-Hyun, Koo, Hyun Jung, Lee, Sang Min, Song, Jin Woo, Lee, Woochang, Lee, Hae Kyung, Do, Kyung-Hyun, Chun, Sail, Min, Won-Ki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Society for Laboratory Medicine 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6340849/
https://ncbi.nlm.nih.gov/pubmed/30623616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3343/alm.2019.39.3.245
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia